Cite
HARVARD Citation
von Dach, E. et al. (2017). Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective. Clinical microbiology and infection. pp. 659-666. [Online].